ATI Pharmacology Proctored Exam 2026/2027 |
ACTUAL-Style Practice Questions & Answers, ATI
RN Pharmacology Proctored Assessment Prep,
Nursing Pharmacology Test Bank, Drug
Classifications, Medication Safety,
Pharmacokinetics, Adverse Effects, Drug
Interactions, Cardiovascular Drugs, Antibiotics,
Insulin, Psychotropic Medications, and Detailed
Rationales
Question 1: A nurse is teaching a client about the purpose of
administering a loading dose of a medication. Which of the
following statements by the client indicates an understanding of
the teaching?
A. "The loading dose ensures the medication reaches a therapeutic level
quickly."
B. "The loading dose is given to prevent allergic reactions."
C. "The loading dose is a smaller dose given to test for adverse effects."
D. "The loading dose is administered to maintain steady-state
concentrations."
CORRECT ANSWER: A. "The loading dose ensures the medication
reaches a therapeutic level quickly."
Rationale: A loading dose is an initial higher dose of a drug that may be
given at the beginning of a course of treatment to rapidly achieve a
therapeutic plasma concentration. It is particularly useful for drugs with
long half-lives where waiting for steady state would delay clinical effect.
Option B describes a test dose, not a loading dose. Option D describes
maintenance dosing.
Question 2: A nurse is reviewing the mechanism of action of a
medication that acts as a competitive antagonist. Which of the
following best describes this mechanism?
A. The drug binds to a receptor and activates a cellular response.
B. The drug binds to a receptor and prevents the agonist from binding.
C. The drug binds to an enzyme and permanently inactivates it.
D. The drug enhances the binding of the natural agonist to the receptor.
CORRECT ANSWER: B. The drug binds to a receptor and prevents
the agonist from binding.
,Rationale: A competitive antagonist binds reversibly to the same receptor
site as the agonist, competing with the agonist for occupancy. This prevents
the agonist from exerting its effect. Option A describes an agonist. Option C
describes an irreversible inhibitor. Option D describes a positive allosteric
modulator.
Question 3: A nurse is caring for a client who has a serum albumin
level of 2.1 g/dL. The nurse should monitor this client for which of
the following medication-related risks?
A. Decreased therapeutic effect of highly protein-bound drugs
B. Increased risk of toxicity from highly protein-bound drugs
C. Rapid excretion of water-soluble drugs
D. Enhanced metabolism of hepatically cleared drugs
CORRECT ANSWER: B. Increased risk of toxicity from highly
protein-bound drugs
Rationale: Albumin is the primary plasma protein responsible for drug
binding. When albumin levels are low (hypoalbuminemia), fewer binding
sites are available. This leads to an increased free fraction of highly protein-
bound drugs in the bloodstream, which can potentiate drug effects and
increase the risk of toxicity. Options A, C, and D are not directly related to
the effect of low albumin on protein-bound drugs.
Question 4: A nurse is preparing to administer a medication that
undergoes extensive first-pass metabolism. The nurse should
anticipate that the prescribed oral dose will be:
A. Lower than the parenteral dose
B. Equal to the parenteral dose
C. Higher than the parenteral dose
D. Unrelated to the parenteral dose
CORRECT ANSWER: C. Higher than the parenteral dose
Rationale: First-pass metabolism refers to the metabolism of a drug in the
liver and gut wall before it reaches systemic circulation. This significantly
reduces the bioavailability of orally administered drugs subject to this
effect. To achieve the same therapeutic blood level as a parenteral dose, a
substantially higher oral dose is often required. Options A and B do not
account for the loss of drug during first-pass metabolism.
,Question 5: A nurse is teaching a client about a medication that is a
potent inducer of cytochrome P450 enzymes. Which of the
following statements by the client indicates a need for further
teaching?
A. "This medication might make my other medications less effective."
B. "I should not be surprised if my warfarin dose needs to be increased."
C. "This medication will increase the levels of my other medications."
D. "My healthcare provider may need to adjust my other prescriptions."
CORRECT ANSWER: C. "This medication will increase the levels of
my other medications."
Rationale: Enzyme inducers increase the activity of cytochrome P450
enzymes, which accelerates the metabolism of substrate drugs. This
typically decreases the plasma levels and therapeutic effect of concurrently
administered medications metabolized by the same enzymes. Therefore,
the statement in option C is incorrect and indicates a need for further
teaching. Options A, B, and D correctly reflect the consequences of enzyme
induction.
Question 6: A nurse is assessing a client who has been taking an
oral medication for several weeks. The nurse notes that the client
has developed tolerance to the medication. Which of the following
best describes this phenomenon?
A. The client has developed an allergy to the medication.
B. The client requires a higher dose to achieve the original effect.
C. The client experiences toxic effects at therapeutic doses.
D. The client's body has increased excretion of the medication.
CORRECT ANSWER: B. The client requires a higher dose to achieve
the original effect.
Rationale: Tolerance is a decreased responsiveness to a drug following
repeated administration, such that a higher dose is required to produce the
same effect originally achieved at a lower dose. It is distinct from allergy
(option A), toxicity (option C), and increased excretion (option D).
Question 7: A nurse is caring for a client who is receiving a
medication with a narrow therapeutic index. Which of the
following nursing actions is most important?
, A. Administer the medication with food to reduce GI upset.
B. Monitor serum drug levels closely.
C. Encourage increased fluid intake.
D. Assess for allergic reactions after the first dose.
CORRECT ANSWER: B. Monitor serum drug levels closely.
Rationale: Drugs with a narrow therapeutic index have a small range
between therapeutic and toxic concentrations. Small changes in dose or
metabolism can lead to subtherapeutic or toxic effects. Therefore, close
monitoring of serum drug levels is essential for safety and efficacy. While
option D is important for any new medication, it is not the most critical
action for narrow therapeutic index drugs.
Question 8: A nurse is reviewing the concept of receptor up-
regulation. This phenomenon would most likely occur with which
of the following?
A. Chronic administration of an agonist drug
B. Chronic administration of an antagonist drug
C. Single-dose administration of a loading dose
D. Acute administration of a competitive antagonist
CORRECT ANSWER: B. Chronic administration of an antagonist
drug
Rationale: Receptor up-regulation is an increase in the number of receptors
on a target cell, often in response to chronic blockade by an antagonist. The
cell attempts to compensate for the lack of stimulation by producing more
receptors. When the antagonist is suddenly withdrawn, the upregulated
receptors may cause an exaggerated response to endogenous agonists.
Chronic agonist administration (option A) typically leads to receptor down-
regulation.
Question 9: A nurse is calculating the half-life of a medication for a
client. The nurse understands that after approximately how many
half-lives will the drug reach steady-state plasma concentration?
A. 1-2 half-lives
B. 2-3 half-lives
C. 4-5 half-lives
D. 8-10 half-lives
ACTUAL-Style Practice Questions & Answers, ATI
RN Pharmacology Proctored Assessment Prep,
Nursing Pharmacology Test Bank, Drug
Classifications, Medication Safety,
Pharmacokinetics, Adverse Effects, Drug
Interactions, Cardiovascular Drugs, Antibiotics,
Insulin, Psychotropic Medications, and Detailed
Rationales
Question 1: A nurse is teaching a client about the purpose of
administering a loading dose of a medication. Which of the
following statements by the client indicates an understanding of
the teaching?
A. "The loading dose ensures the medication reaches a therapeutic level
quickly."
B. "The loading dose is given to prevent allergic reactions."
C. "The loading dose is a smaller dose given to test for adverse effects."
D. "The loading dose is administered to maintain steady-state
concentrations."
CORRECT ANSWER: A. "The loading dose ensures the medication
reaches a therapeutic level quickly."
Rationale: A loading dose is an initial higher dose of a drug that may be
given at the beginning of a course of treatment to rapidly achieve a
therapeutic plasma concentration. It is particularly useful for drugs with
long half-lives where waiting for steady state would delay clinical effect.
Option B describes a test dose, not a loading dose. Option D describes
maintenance dosing.
Question 2: A nurse is reviewing the mechanism of action of a
medication that acts as a competitive antagonist. Which of the
following best describes this mechanism?
A. The drug binds to a receptor and activates a cellular response.
B. The drug binds to a receptor and prevents the agonist from binding.
C. The drug binds to an enzyme and permanently inactivates it.
D. The drug enhances the binding of the natural agonist to the receptor.
CORRECT ANSWER: B. The drug binds to a receptor and prevents
the agonist from binding.
,Rationale: A competitive antagonist binds reversibly to the same receptor
site as the agonist, competing with the agonist for occupancy. This prevents
the agonist from exerting its effect. Option A describes an agonist. Option C
describes an irreversible inhibitor. Option D describes a positive allosteric
modulator.
Question 3: A nurse is caring for a client who has a serum albumin
level of 2.1 g/dL. The nurse should monitor this client for which of
the following medication-related risks?
A. Decreased therapeutic effect of highly protein-bound drugs
B. Increased risk of toxicity from highly protein-bound drugs
C. Rapid excretion of water-soluble drugs
D. Enhanced metabolism of hepatically cleared drugs
CORRECT ANSWER: B. Increased risk of toxicity from highly
protein-bound drugs
Rationale: Albumin is the primary plasma protein responsible for drug
binding. When albumin levels are low (hypoalbuminemia), fewer binding
sites are available. This leads to an increased free fraction of highly protein-
bound drugs in the bloodstream, which can potentiate drug effects and
increase the risk of toxicity. Options A, C, and D are not directly related to
the effect of low albumin on protein-bound drugs.
Question 4: A nurse is preparing to administer a medication that
undergoes extensive first-pass metabolism. The nurse should
anticipate that the prescribed oral dose will be:
A. Lower than the parenteral dose
B. Equal to the parenteral dose
C. Higher than the parenteral dose
D. Unrelated to the parenteral dose
CORRECT ANSWER: C. Higher than the parenteral dose
Rationale: First-pass metabolism refers to the metabolism of a drug in the
liver and gut wall before it reaches systemic circulation. This significantly
reduces the bioavailability of orally administered drugs subject to this
effect. To achieve the same therapeutic blood level as a parenteral dose, a
substantially higher oral dose is often required. Options A and B do not
account for the loss of drug during first-pass metabolism.
,Question 5: A nurse is teaching a client about a medication that is a
potent inducer of cytochrome P450 enzymes. Which of the
following statements by the client indicates a need for further
teaching?
A. "This medication might make my other medications less effective."
B. "I should not be surprised if my warfarin dose needs to be increased."
C. "This medication will increase the levels of my other medications."
D. "My healthcare provider may need to adjust my other prescriptions."
CORRECT ANSWER: C. "This medication will increase the levels of
my other medications."
Rationale: Enzyme inducers increase the activity of cytochrome P450
enzymes, which accelerates the metabolism of substrate drugs. This
typically decreases the plasma levels and therapeutic effect of concurrently
administered medications metabolized by the same enzymes. Therefore,
the statement in option C is incorrect and indicates a need for further
teaching. Options A, B, and D correctly reflect the consequences of enzyme
induction.
Question 6: A nurse is assessing a client who has been taking an
oral medication for several weeks. The nurse notes that the client
has developed tolerance to the medication. Which of the following
best describes this phenomenon?
A. The client has developed an allergy to the medication.
B. The client requires a higher dose to achieve the original effect.
C. The client experiences toxic effects at therapeutic doses.
D. The client's body has increased excretion of the medication.
CORRECT ANSWER: B. The client requires a higher dose to achieve
the original effect.
Rationale: Tolerance is a decreased responsiveness to a drug following
repeated administration, such that a higher dose is required to produce the
same effect originally achieved at a lower dose. It is distinct from allergy
(option A), toxicity (option C), and increased excretion (option D).
Question 7: A nurse is caring for a client who is receiving a
medication with a narrow therapeutic index. Which of the
following nursing actions is most important?
, A. Administer the medication with food to reduce GI upset.
B. Monitor serum drug levels closely.
C. Encourage increased fluid intake.
D. Assess for allergic reactions after the first dose.
CORRECT ANSWER: B. Monitor serum drug levels closely.
Rationale: Drugs with a narrow therapeutic index have a small range
between therapeutic and toxic concentrations. Small changes in dose or
metabolism can lead to subtherapeutic or toxic effects. Therefore, close
monitoring of serum drug levels is essential for safety and efficacy. While
option D is important for any new medication, it is not the most critical
action for narrow therapeutic index drugs.
Question 8: A nurse is reviewing the concept of receptor up-
regulation. This phenomenon would most likely occur with which
of the following?
A. Chronic administration of an agonist drug
B. Chronic administration of an antagonist drug
C. Single-dose administration of a loading dose
D. Acute administration of a competitive antagonist
CORRECT ANSWER: B. Chronic administration of an antagonist
drug
Rationale: Receptor up-regulation is an increase in the number of receptors
on a target cell, often in response to chronic blockade by an antagonist. The
cell attempts to compensate for the lack of stimulation by producing more
receptors. When the antagonist is suddenly withdrawn, the upregulated
receptors may cause an exaggerated response to endogenous agonists.
Chronic agonist administration (option A) typically leads to receptor down-
regulation.
Question 9: A nurse is calculating the half-life of a medication for a
client. The nurse understands that after approximately how many
half-lives will the drug reach steady-state plasma concentration?
A. 1-2 half-lives
B. 2-3 half-lives
C. 4-5 half-lives
D. 8-10 half-lives
